Skip to main content
. 2022 Aug 7;19(15):9718. doi: 10.3390/ijerph19159718

Table 6.

Association of clinical variables with KDQOL-SF summary scores of the patients.

Variables IPD (n = 90) p Value OPD (n = 90) p Value
Mean ± SD Mean ± SD
Co-morbidities DM 55.45 ± 8.55 0.2688
NS
65.91 ± 4.89 0.0186 *
HT 50.71 ± 10.05 63.81 ± 3.55
Heart disease 52.78 ± 10.2 66.35 ± 5.86
None 52.09 ± 9.52 61.85 ± 5.23
Stage of CKD 1 69.46 ± 5.58 69.61 ± 3.02 0.0001 *
2 66.38 ± 4.64 63.09 ± 1.78
3 53.71 ± 3.31 0.0001 * 61.46 ± 2.83
4 45.46 ± 3.25 57.1 ± 2.09
5 39.44 ± 1.86 53.37 ± 0.83
Duration of CKD 1–3 years 71.74 ± 2.63 0.0001 * 67.94 ± 3.62
4–6 years 59.31 ± 4.17 65.26 ± 3.43
7–9 years 48.2 ± 4.04 63.66 ± 5.81 0.1086
10 and above years 41.34 ± 2.87 63.65 ± 5.19 NS
Treatment of CKD Hemodialysis 44.02 ± 3.82 0.0001 * 62.17 ± 7.28
Immunosuppressants 54.53 ± 2.69 63.45 ± 3.41 0.0004 *
Others 66.4 ± 5.78 67.2 ± 4.24

* Statistically significant at p < 0.05; NS—non-significant.